Detalhe da pesquisa
1.
Monitoring Drug Safety in Pregnancy with Scan Statistics: A Comparison of Two Study Designs.
Epidemiology
; 34(1): 90-98, 2023 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36252086
2.
Outcomes of the "BRCA Quality Improvement Dissemination Program": An initiative to improve patient receipt of cancer genetics services at five health systems.
Gynecol Oncol
; 172: 106-114, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37004303
3.
Novel methods for pregnancy drug safety surveillance in the FDA Sentinel System.
Pharmacoepidemiol Drug Saf
; 32(2): 126-136, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-35871766
4.
Incidence of severe uterine bleeding outcomes among oral anticoagulant users and nonusers.
Am J Obstet Gynecol
; 226(1): 140-143, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34481779
5.
Incidence of uterine bleeding following oral anticoagulant use in Food and Drug Administration's Sentinel System.
Am J Obstet Gynecol
; 224(4): 403-404, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33248974
6.
Detection of SARS-CoV-2 antibodies after confirmed Omicron BA.1 and presumed BA.4/5 infections using Abbott ARCHITECT and Panbio assays.
IJID Reg
; 7: 277-280, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37234563
7.
Building Blocks for the Long-acting and Permanent Contraceptives Coordinated Registry Network.
BMJ Surg Interv Health Technol
; 4(Suppl 1): e000075, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36393889
8.
Risk of Severe Abnormal Uterine Bleeding Associated with Rivaroxaban Compared with Apixaban, Dabigatran and Warfarin.
Drug Saf
; 44(7): 753-763, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34014506